2024 MIPS eCQMs
All measures will be calculated. Must submit at least 6, with at least one outcome measure.
Collection Type |
| Guideline Name |
MIPS eCQM CMS124 |
| Quality ID: 309 Cervical Cancer Screening |
MIPS eCQM CMS068 |
| Quality ID: 130 Documentation of Current Medications in the Medical Record |
MIPS eCQM |
| Quality ID: 134 Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
MIPS eCQM CMS157 |
| Quality ID: 143 Oncology: Medical and Radiation - Pain Intensity Quantified |
MIPS eCQM CMS129 |
| Quality ID: 102 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients |
MIPS eCQM |
| Quality ID: 462 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy |
MIPS eCQM CMS138 |
| Quality ID: 226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
MIPS eCQM CMS139 |
| Quality ID: 318 Falls: Screening for Future Fall Risk |
MIPS eCQM CMS165 |
| Quality ID: 236 Controlling High Blood Pressure |
Measure Specifications
Go to https://qpp.cms.gov/mips/explore-measures then select the performance year and search for the desired measure. Each measure has a link to the measure specification.
2024 Advancing Cancer Care MVP
Must submit 4, with at least 1 outcome measure.
Collection Type |
| Guideline Name |
MIPS CQM |
| Quality ID: 047 Advance Care Plan |
MIPS eCQM |
| Quality ID: 134 Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
MIPS eCQM CMS157 |
| Quality ID: 143 Oncology: Medical and Radiation - Pain Intensity Quantified |
MIPS CQM |
| Quality ID: 144 Oncology: Medical and Radiation - Plan of Care for Pain |
MIPS CQM |
| Quality ID: 450 Appropriate Treatment for Patients with Stage I (T1c) - III HER2 Positive Breast Cancer |
MIPS CQM |
| Quality ID: 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy |
MIPS CQM |
| Quality ID: 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies |
MIPS CQM |
| Quality ID: 453 Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better) |
MIPS CQM |
| Quality ID: 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score - better) |
MIPS eCQM |
| Quality ID: 462 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy |
MIPS CQM |
| Quality ID: 487 Screening for Social Drivers of Health |
MIPS CQM |
| Quality ID: 490 Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors |
Measure Specifications
Go to MVP ID: M0001 Explore Merit-based Incentive Payment System (MIPS) Value Pathways (MVPs) - QPP
scroll down to the Quality section and expand to view the current list of measures and links to each measure specification.